0001104659-23-112568.txt : 20231030 0001104659-23-112568.hdr.sgml : 20231030 20231030161140 ACCESSION NUMBER: 0001104659-23-112568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231026 FILED AS OF DATE: 20231030 DATE AS OF CHANGE: 20231030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Myers Michael CENTRAL INDEX KEY: 0001959547 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37846 FILM NUMBER: 231360325 MAIL ADDRESS: STREET 1: AZRIELI CENTER STREET 2: ROUND TOWER, 30TH FLOOR CITY: TEL AVIV STATE: L3 ZIP: 6701101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quoin Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001671502 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 BUSINESS ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 BUSINESS PHONE: 97299741444 MAIL ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biotechnology Ltd. DATE OF NAME CHANGE: 20160721 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biomed Ltd. DATE OF NAME CHANGE: 20160406 4 1 tm2329341-7_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-10-26 0 0001671502 Quoin Pharmaceuticals, Ltd. QNRX 0001959547 Myers Michael C/O QUOIN PHARMACEUTICALS LTD. 42127 PLEASANT FOREST COURT ASHBURN VA 20148 1 1 0 0 Chief Executive Officer 0 Share Option (Right to Buy) 5.75 2023-10-26 4 A 0 80965 0 A 2024-10-26 2033-10-26 American Depositary Share 80965 80965 D The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS. The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027. /s/ Michael Myers 2023-10-30